Shandong Sinobioway Biomedicine Co., Ltd.
SZSE:002581.SZ
15.12 (CNY) • At close October 26, 2023
Overzicht | Financiële gegevens
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Omzet
| 360.405 | 429.79 | 357.081 | 402.713 | 276.83 | 567.637 | 664.594 | 1,162.417 | 1,264.879 | 858.286 | 319.14 | 317.254 | 285.344 | 246.369 | 247.173 | 213.799 | 177.252 | 150.03 |
| Kosten van de omzet
| 72.857 | 93.287 | 76.212 | 85.834 | 54.326 | 74.141 | 98.554 | 255.664 | 299.345 | 142.407 | 191.623 | 178.093 | 157.945 | 128.658 | 128.861 | 110.181 | 111.031 | 90.647 |
| Brutowinst
| 287.548 | 336.503 | 280.869 | 316.879 | 222.505 | 493.496 | 566.039 | 906.753 | 965.534 | 715.879 | 127.516 | 139.16 | 127.399 | 117.712 | 118.312 | 103.618 | 66.221 | 59.383 |
| Brutowinstmarge
| 0.798 | 0.783 | 0.787 | 0.787 | 0.804 | 0.869 | 0.852 | 0.78 | 0.763 | 0.834 | 0.4 | 0.439 | 0.446 | 0.478 | 0.479 | 0.485 | 0.374 | 0.396 |
| Onderzoek- en ontwikkelingskosten
| 25.374 | 59.799 | 27.289 | 38.438 | 49.296 | 54.655 | 45.953 | 39.019 | 44.003 | 29.444 | 12.201 | 12.012 | 11.492 | 10.757 | 11.235 | 0 | 0 | 0 |
| Algemene en administratieve kosten
| 57.043 | 117.185 | 82.82 | 89.327 | 93.372 | 73.078 | 89.268 | 59.214 | 52.86 | 37.353 | 6.046 | 6.953 | 9.184 | 12.554 | 5.444 | 22.128 | 15.144 | 13.653 |
| Verkoop- en marketingkosten
| 253.401 | 288.298 | 292.478 | 345.334 | 286.243 | 422.456 | 394.601 | 389.241 | 408.65 | 347.399 | 12.905 | 13.191 | 10.639 | 7.922 | 8.886 | 8.419 | 7.305 | 8.314 |
| Verkoop-, algemene en administratieve kosten
| 310.444 | 405.482 | 375.297 | 434.662 | 379.615 | 495.535 | 483.87 | 448.455 | 461.509 | 384.752 | 18.951 | 20.144 | 19.824 | 20.476 | 14.33 | 30.547 | 22.449 | 21.967 |
| Overige kosten
| 63.202 | 144.319 | 45.688 | 35.021 | 31.46 | 31.873 | 14.486 | -1.014 | 9.543 | 5.954 | 1.403 | 0.885 | 0.328 | 0.884 | 0.31 | -1.851 | -0.348 | -1.015 |
| Bedrijfskosten
| 399.02 | 629.854 | 448.274 | 508.121 | 460.371 | 582.063 | 560.31 | 503.25 | 537.873 | 436.693 | 43.92 | 43.852 | 41.09 | 41.695 | 33.828 | 30.547 | 22.449 | 21.967 |
| Bedrijfsresultaat
| -111.472 | -293.351 | 33.671 | 273.082 | -237.866 | 105.864 | -87.245 | 465.169 | 449.179 | 276.092 | 94.288 | 102.333 | 101.086 | 78.24 | 83.901 | 71.386 | 42.695 | 39.095 |
| Bedrijfsresultaat ratio
| -0.309 | -0.683 | 0.094 | 0.678 | -0.859 | 0.186 | -0.131 | 0.4 | 0.355 | 0.322 | 0.295 | 0.323 | 0.354 | 0.318 | 0.339 | 0.334 | 0.241 | 0.261 |
| Totaal overige inkomsten en kosten netto
| -34.704 | -19.899 | -20.947 | 5.516 | -6.104 | -2.239 | -1.767 | -1.04 | 9.35 | 5.869 | 43.676 | 0.885 | 0.308 | 0.884 | 0.31 | -1.864 | -1.205 | -1.633 |
| Inkomen voor belasting
| -146.176 | -313.25 | 12.725 | 278.598 | -201.764 | 76.768 | -89.012 | 464.129 | 456.561 | 281.961 | 95.691 | 103.217 | 101.394 | 79.124 | 84.21 | 69.522 | 42.347 | 37.462 |
| Inkomen voor belasting ratio
| -0.406 | -0.729 | 0.036 | 0.692 | -0.729 | 0.135 | -0.134 | 0.399 | 0.361 | 0.329 | 0.3 | 0.325 | 0.355 | 0.321 | 0.341 | 0.325 | 0.239 | 0.25 |
| Belastingkosten
| -3.34 | 8.885 | 13.593 | -0.091 | -3.587 | 3.684 | 9.214 | 73.22 | 40.046 | 41.658 | 14.213 | 15.18 | 15.123 | 12.147 | 13.955 | 10.698 | 5.304 | 4.83 |
| Nettowinst
| -137.314 | -332.458 | -0.868 | 271.002 | -198.177 | 63.384 | -95.789 | 388.412 | 417.695 | 250.254 | 81.479 | 88.037 | 86.271 | 66.976 | 70.256 | 58.824 | 37.043 | 32.633 |
| Nettowinstmarge
| -0.381 | -0.774 | -0.002 | 0.673 | -0.716 | 0.112 | -0.144 | 0.334 | 0.33 | 0.292 | 0.255 | 0.277 | 0.302 | 0.272 | 0.284 | 0.275 | 0.209 | 0.218 |
| WPA (Winst Per Aandeel)
| -0.6 | -0.5 | -0.001 | 0.41 | -0.3 | 0.096 | -0.15 | 0.59 | 0.63 | 0.56 | 0.59 | 0.32 | 0.31 | 0.27 | 0.33 | 0.28 | 0.18 | 0.18 |
| Verwaterde WPA
| -0.6 | -0.5 | -0.001 | 0.41 | -0.3 | 0.096 | -0.15 | 0.59 | 0.63 | 0.56 | 0.59 | 0.32 | 0.31 | 0.27 | 0.33 | 0.28 | 0.18 | 0.18 |
| EBITDA
| -104.309 | -233.982 | 106.068 | 351.249 | -116.685 | 163.859 | 30.242 | 527.971 | 496.062 | 328.956 | 228.388 | 104.228 | 108.826 | 87.445 | 92.635 | 81.104 | 49.989 | 41.349 |
| EBITDA ratio
| -0.289 | -0.544 | 0.297 | 0.872 | -0.422 | 0.289 | 0.046 | 0.454 | 0.392 | 0.383 | 0.716 | 0.329 | 0.381 | 0.355 | 0.375 | 0.379 | 0.282 | 0.276 |